(LENALIDOMIDE 5 MG CAP)
ONCOLOGY(LENALIDOMIDE 5 MG CAP)
ONCOLOGYLENALIBAY 5 is typically prescribed for the following conditions:
1. Multiple myeloma: It is used in combination with other medications to treat multiple myeloma in patients who have received previous treatments.
2. Myelodysplastic syndromes (MDS): Lenalidomide may also be used to treat certain types of MDS, a group of disorders of the bone marrow.
LENALIBAY 5 contains the active ingredient Lenalidomide. Lenalidomide is an immunomodulatory medication that affects the immune system and is used in the treatment of various conditions. It is particularly used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. Lenalidomide works by several mechanisms, including inhibiting the growth of cancer cells, altering the immune system's response to cancer, and reducing inflammation
LENALIBAY 5 is typically prescribed for the following conditions:
1. Multiple myeloma: It is used in combination with other medications to treat multiple myeloma in patients who have received previous treatments.
2. Myelodysplastic syndromes (MDS): Lenalidomide may also be used to treat certain types of MDS, a group of disorders of the bone marrow.
The dosage of LENALIBAY 5 will vary depending on the specific condition being treated, the patient's overall health, and the doctor's recommendations.
It is typically taken orally, usually once daily.
Follow your healthcare provider's instructions regarding the dosage and duration of treatment.
LENALIBAY 5 may cause side effects in some individuals. Common side effects may include:
1. Fatigue
2. Nausea
3. Diarrhea
4. Constipation
5. Skin rash
6. Low white blood cell count (neutropenia)
7. Low platelet count (thrombocytopenia)
8. Elevated liver enzymes
LENALIBAY 5 should not be used in certain situations, including:
1. Hypersensitivity or allergy to Lenalidomide or any other components of the medication.
2. Pregnancy or the intention to become pregnant.